Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Breast 1

Conditions

Fasting 2Intermittent Fasting 1Fibrosis 1Esophageal Neoplasms 1Colorectal Neoplasms 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Angptl4 protein, mouse × Gastrointestinal × Clear all
NCT04247464 2023-10-05

CHEMOFAST

IMDEA Food

Phase NA Completed
11 enrolled
Gastrointestinal

Intermittent Fasting, Fasting, Colorectal Neoplasms

NCT03706846 2018-10-16

GASTROPREP

Centre Hospitalier Universitaire de Besancon

Phase NA Completed
70 enrolled
Gastrointestinal

Esophageal Neoplasms, Fasting, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡